Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity-Reference-Cited by-同舟云学术

Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity

Published:2012 Issue:2 Volume:14 Page:R48
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Suzuki Fumihito,Kubota Tetsuo,Miyazaki Yasunari,Ishikawa Kinya,Ebisawa Masashi,Hirohata Shunsei,Ogura Takashi,Mizusawa Hidehiro,Imai Toshio,Miyasaka Nobuyuki,Nanki Toshihiro

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference26 articles.

1. Cytokine Expression Profile in Idiopathic Inflammatory Myopathies

2. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis.

3. Interstitial lung disease in polymyositis and dermatomyositis

4. Reliability and validity of the myositis disease activity assessment tool

5. Chemokines — Chemotactic Cytokines That Mediate Inflammation

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Myokine Profiles in Patients With AChR- and MuSK-Ab-Positive Myasthenia Gravis;Journal of Clinical Neurology;2023

2. Proteomics Analysis of Plasma-Derived Exosomes Unveils the Aberrant Complement and Coagulation Cascades in Dermatomyositis/Polymyositis;Journal of Proteome Research;2022-12-12

3. Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice;Pharmaceuticals;2021-05-17

Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases

;ImmunoTargets and Therapy;2020-11

5. Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases;Expert Opinion on Biological Therapy;2020-05-13